In this study, for the first time, we show that CD90 is directly modulated by NOTCH and that a NOTCH1 γ-secretase inhibitor effectively reduces the progression of iCCA expressing high levels of CD90. The gene discussed is NOTCH1; the disease is infantile convulsions and choreoathetosis.